Glenfield Hospital, formally known as Glenfield General Hospital, is situated near Glenfield, on the outskirts of Leicester. It is one of England's main hospitals for coronary care and respiratory diseases.

During the past decade, Glenfield Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 21 clinical trials were completed, i.e. on average, 42% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 11 clinical trials were completed. i.e. 57.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Glenfield Hospital" #1 sponsor was "University of Leicester" with 9 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored, "Biosense Webster, Inc." with 4 trials sponsored and "Boston Scientific Corporation" with 4 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glenfield Hospital" #1 collaborator was "British Heart Foundation" with 7 trials as a collaborator, "University of Glasgow" with 5 trials as a collaborator, "University Hospitals, Leicester" with 4 trials as a collaborator, "Royal Brompton & Harefield NHS Foundation Trust" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Glenfield Hospital" are "Asthma" (8 trials), "Coronary Artery Disease" (8 trials), "Heart Failure" (8 trials), "Aortic Valve Stenosis" (3 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Glenfield Hospital" in a lesser frequency.

Most popular intervention types in "Glenfield Hospital" are "Drug" (37 trials), "Device" (27 trials), "Procedure" (13 trials), "Other" (11 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "placebo" (3 trials), "Aspirin" (2 trials), "Empagliflozin" (2 trials) and "ICD" (2 trials). Other intervention names were less common.

The vast majority of trials in "Glenfield Hospital" are 86 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Glenfield Hospital". 1 are not yet recruiting, 13 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Glenfield Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Glenfield Hospital, 2 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 20 trials that are defined as “Not Applicable".